New STAT report explores viral vectors, the linchpin of gene therapy
STAT's latest report takes a deep dive into a crucial component of gene therapies: the viral vectors used to deliver the modified genes to cells and organs.
by STAT staff
Dec 11, 2019
1 minute
Gene therapy, once dismissed as too dangerous, has made a comeback, with two products approved in the U.S. since December 2017 and hundreds more in the pipeline. STAT’s latest report takes
You’re reading a preview, subscribe to read more.
Start your free 30 days